> > Speaker Biographical Information

Marc Abrams

Short Bio:

As Senior Director, Preclinical Research at Dicerna Pharmaceuticals, I lead programs for specific targets/indications and support optimization of our RNA interference technology platforms. I joined Dicerna in 2014 after 16 years at Merck and Co., Inc, where I held positions from Staff Biochemist through Associate Director. During that tenure, I worked as a biologist and pharmacologist on discovery programs across different modalities (small molecule and nucleic acid therapeutics) in oncology, virology and immunology. I hold a Ph.D. in Biochemistry from Thomas Jefferson University and have authored or co-authored over 30 peer-reviewed publications.